The Biden administration has yet to provide the U.S. Drug Enforcement Administration a “specific timeline” to complete its review of marijuana’s status under federal law, the agency’s chief told members of Congress on Thursday.
That prompted one lawmaker to vow to speed things along.
“We’re going to get this moving,” said U.S. Rep. Steve Cohen, a Democrat from Tennessee.
ADVERTISEMENT
Last fall, President Joe Biden triggered an “administrative review” of marijuana’s classification in the Controlled Substances Act.
Public health agencies, including the U.S. Food and Drug Administration and the Department of Health and Human Services, are currently reviewing published science and data.
That includes data from medical marijuana programs submitted by state regulators.
After the science is considered, health agencies deliver a recommendation to the DEA.
That process will “hopefully” be completed by the end of the year, Health Secretary Xavier Becerra said in June.
But on
Read full article on Marijuana Business Daily
